vs
Biofrontera Inc.（BFRI）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Biofrontera Inc.的季度营收约是Finward Bancorp的1.0倍（$17.1M vs $16.5M），Biofrontera Inc.净利率更高（33.0% vs 12.0%，领先21.0%），Biofrontera Inc.同比增速更快（36.2% vs 1.1%），Finward Bancorp自由现金流更多（$9.0M vs $-2.4M），过去两年Biofrontera Inc.的营收复合增速更高（47.0% vs -19.1%）
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
BFRI vs FNWD — 直观对比
营收规模更大
BFRI
是对方的1.0倍
$16.5M
营收增速更快
BFRI
高出35.1%
1.1%
净利率更高
BFRI
高出21.0%
12.0%
自由现金流更多
FNWD
多$11.4M
$-2.4M
两年增速更快
BFRI
近两年复合增速
-19.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $16.5M |
| 净利润 | $5.6M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | 26.6% | 11.0% |
| 净利率 | 33.0% | 12.0% |
| 营收同比 | 36.2% | 1.1% |
| 净利润同比 | 504.0% | -5.6% |
| 每股收益（稀释后） | $0.62 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFRIFNWD
| Q4 25 | $17.1M | $16.5M | ||
| Q3 25 | $7.0M | $17.4M | ||
| Q2 25 | $9.0M | $16.6M | ||
| Q1 25 | $8.6M | $15.5M | ||
| Q4 24 | $12.6M | $16.3M | ||
| Q3 24 | $9.0M | $14.9M | ||
| Q2 24 | $7.8M | $14.6M | ||
| Q1 24 | $7.9M | $25.3M |
净利润BFRIFNWD
| Q4 25 | $5.6M | $2.0M | ||
| Q3 25 | $-6.6M | $3.5M | ||
| Q2 25 | $-5.3M | $2.2M | ||
| Q1 25 | $-4.2M | $455.0K | ||
| Q4 24 | $-1.4M | $2.1M | ||
| Q3 24 | $-5.7M | $606.0K | ||
| Q2 24 | $-257.0K | $143.0K | ||
| Q1 24 | $-10.4M | $9.3M |
营业利润率BFRIFNWD
| Q4 25 | 26.6% | 11.0% | ||
| Q3 25 | -89.8% | 20.5% | ||
| Q2 25 | -56.2% | 12.7% | ||
| Q1 25 | -52.9% | 4.0% | ||
| Q4 24 | -13.6% | 16.3% | ||
| Q3 24 | -55.0% | 2.7% | ||
| Q2 24 | -64.7% | 0.9% | ||
| Q1 24 | -69.1% | 40.6% |
净利率BFRIFNWD
| Q4 25 | 33.0% | 12.0% | ||
| Q3 25 | -95.1% | 20.1% | ||
| Q2 25 | -59.0% | 12.9% | ||
| Q1 25 | -48.9% | 2.9% | ||
| Q4 24 | -11.1% | 12.9% | ||
| Q3 24 | -62.9% | 4.1% | ||
| Q2 24 | -3.3% | 1.0% | ||
| Q1 24 | -131.9% | 36.7% |
每股收益（稀释后）BFRIFNWD
| Q4 25 | $0.62 | $0.46 | ||
| Q3 25 | $-0.62 | $0.81 | ||
| Q2 25 | $-0.57 | $0.50 | ||
| Q1 25 | $-0.47 | $0.11 | ||
| Q4 24 | $0.69 | $0.50 | ||
| Q3 24 | $-0.98 | $0.14 | ||
| Q2 24 | $-0.05 | $0.03 | ||
| Q1 24 | $-2.88 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.5M | $174.7M |
| 总资产 | $28.6M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BFRIFNWD
| Q4 25 | $6.4M | — | ||
| Q3 25 | $3.4M | — | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $3.8M | — |
股东权益BFRIFNWD
| Q4 25 | $10.5M | $174.7M | ||
| Q3 25 | $-2.6M | $165.5M | ||
| Q2 25 | $-4.7M | $154.3M | ||
| Q1 25 | $500.0K | $151.8M | ||
| Q4 24 | $4.4M | $151.4M | ||
| Q3 24 | $5.5M | $159.6M | ||
| Q2 24 | $10.9M | $148.6M | ||
| Q1 24 | $-5.4M | $151.6M |
总资产BFRIFNWD
| Q4 25 | $28.6M | $2.0B | ||
| Q3 25 | $15.4M | $2.1B | ||
| Q2 25 | $20.1M | $2.1B | ||
| Q1 25 | $16.6M | $2.0B | ||
| Q4 24 | $22.1M | $2.1B | ||
| Q3 24 | $18.5M | $2.1B | ||
| Q2 24 | $21.6M | $2.1B | ||
| Q1 24 | $24.6M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $9.0M |
| 自由现金流率自由现金流/营收 | -13.9% | 54.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.2% |
| 现金转化率经营现金流/净利润 | -0.42× | 4.99× |
| 过去12个月自由现金流最近4个季度 | $-13.4M | $10.6M |
8季度趋势，按日历期对齐
经营现金流BFRIFNWD
| Q4 25 | $-2.4M | $9.9M | ||
| Q3 25 | $-3.8M | $1.2M | ||
| Q2 25 | $-3.0M | $4.8M | ||
| Q1 25 | $-4.1M | $-3.8M | ||
| Q4 24 | $-1.0M | $9.8M | ||
| Q3 24 | $-1.2M | $-3.7M | ||
| Q2 24 | $-4.7M | $2.8M | ||
| Q1 24 | $-3.3M | $-25.0K |
自由现金流BFRIFNWD
| Q4 25 | $-2.4M | $9.0M | ||
| Q3 25 | $-3.8M | $1.0M | ||
| Q2 25 | $-3.0M | $4.5M | ||
| Q1 25 | $-4.1M | $-4.0M | ||
| Q4 24 | $-1.0M | $6.7M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | $-4.8M | $1.1M | ||
| Q1 24 | $-3.4M | $-736.0K |
自由现金流率BFRIFNWD
| Q4 25 | -13.9% | 54.8% | ||
| Q3 25 | -54.7% | 6.0% | ||
| Q2 25 | -33.7% | 27.0% | ||
| Q1 25 | -48.0% | -25.7% | ||
| Q4 24 | -8.1% | 41.2% | ||
| Q3 24 | — | -28.5% | ||
| Q2 24 | -60.8% | 7.6% | ||
| Q1 24 | -42.7% | -2.9% |
资本支出强度BFRIFNWD
| Q4 25 | 0.0% | 5.2% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 18.8% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | 0.6% | 11.2% | ||
| Q1 24 | 0.7% | 2.8% |
现金转化率BFRIFNWD
| Q4 25 | -0.42× | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
